{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:06:15Z","timestamp":1790863575227,"version":"4.1.0"},"reference-count":20,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2026,9,21]]},"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:p>Dermatomyositis is a recognised paraneoplastic inflammatory myopathy although its association with oesophageal malignancy is uncommon. Most reported cases either precede or accompany the initial diagnosis of malignancy. We report a man in his late fifties with previously treated oesophageal squamous cell carcinoma who developed florid dermatomyositis after approximately 6 years of sustained remission following chemotherapy, radiotherapy and pembrolizumab therapy. He presented with progressive proximal muscle weakness, dysphagia and characteristic cutaneous manifestations accompanied by markedly elevated creatine kinase levels. Fluorodeoxyglucose positron emission tomography-CT demonstrated metastatic oesophageal squamous cell carcinoma involving the thoracic oesophagus, abdominal lymph nodes and liver. Corticosteroids followed by paclitaxel\u2013carboplatin rechallenge chemotherapy resulted in marked improvement in both inflammatory manifestations and tumour burden. The chronology was notable for parallel evolution of inflammatory activity and metastatic disease after prolonged oncological remission.<\/jats:p>","DOI":"10.1136\/bcr-2026-275507","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:43:42Z","timestamp":1790862222000},"page":"e275507","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Paraneoplastic dermatomyositis preceding detection of metastatic oesophageal squamous cell carcinoma after prolonged remission following pembrolizumab therapy"],"prefix":"10.1136","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5727-1887","authenticated-orcid":false,"given":"Syed Adil","family":"Hassan","sequence":"first","affiliation":[{"name":"Medical Oncology, Apollo Hospitals Guwahati, Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7579-136X","authenticated-orcid":false,"given":"Kasturi","family":"Hazarika","sequence":"additional","affiliation":[{"name":"Clinical Immunology and Rheumatology, Apollo Hospitals Guwahati, Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant Kumar","family":"Rai","sequence":"additional","affiliation":[{"name":"Medical Gastroenterology, Apollo Hospitals Guwahati, Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"2026100106251933000_19.10.e275507.1","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/acr.24786","article-title":"Incidence, prevalence, and mortality of dermatomyositis: a population-based cohort study","volume":"75","author":"Kronzer","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026100106251933000_19.10.e275507.2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1203475416665601","article-title":"Risk of Malignancy in Dermatomyositis and Polymyositis","volume":"21","author":"Qiang","year":"2017","journal-title":"J Cutan Med Surg"},{"key":"2026100106251933000_19.10.e275507.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-023-01045-w"},{"key":"2026100106251933000_19.10.e275507.4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2340\/00015555-3091","article-title":"Use of Anti-transcriptional Intermediary Factor-1 Gamma Autoantibody in Identifying Adult Dermatomyositis Patients with Cancer: A Systematic Review and Meta-analysis","volume":"99","author":"Best","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"2026100106251933000_19.10.e275507.5","doi-asserted-by":"publisher","DOI":"10.1177\/014107688507800915"},{"key":"2026100106251933000_19.10.e275507.6","doi-asserted-by":"publisher","DOI":"10.1097\/01.smj.0000215732.28409.af"},{"key":"2026100106251933000_19.10.e275507.7","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1365-4632.2008.03486.x","article-title":"Amyopathic dermatomyositis associated with esophageal cancer","volume":"47","author":"Kikuchi","year":"2008","journal-title":"Int J Dermatol"},{"key":"2026100106251933000_19.10.e275507.8","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-215047","article-title":"Cancer-associated myositis associated with oesophageal adenocarcinoma arising in Barrett\u2019s oesophagus without serum myogenic enzymes elevation: an example suggesting the importance of MRI","volume":"2016","author":"Sasaki","year":"2016","journal-title":"BMJ Case Rep"},{"key":"2026100106251933000_19.10.e275507.9","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-227387","article-title":"Dermatomyositis as a paraneoplastic phenomenon in oesophageal cancer","volume":"11","author":"Laidler","year":"2018","journal-title":"BMJ Case Rep"},{"key":"2026100106251933000_19.10.e275507.10","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.922004","article-title":"A Case of Dermatomyositis Along with Esophageal Cancer and Screening of Serum Transcriptional Intermediary Factor 1 Gamma Antibodies in Various Cancer Patients","volume":"21","author":"Sumazaki","year":"2020","journal-title":"Am J Case Rep"},{"key":"2026100106251933000_19.10.e275507.11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.21037\/aoe-23-23","article-title":"Unveiling the complex nexus: dermatomyositis and esophageal adenocarcinoma\u2014a case report","volume":"7","author":"Gon\u00e7alves","year":"2024","journal-title":"Ann Esophagus"},{"key":"2026100106251933000_19.10.e275507.12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.803410","article-title":"Incidence and Distinct Features of Immune Checkpoint Inhibitor-Related Myositis From Idiopathic Inflammatory Myositis: A Single-Center Experience With Systematic Literature Review and Meta-Analysis","volume":"12","author":"Hamada","year":"2021","journal-title":"Front Immunol"},{"key":"2026100106251933000_19.10.e275507.13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211468"},{"key":"2026100106251933000_19.10.e275507.14","doi-asserted-by":"crossref","first-page":"103375","DOI":"10.1016\/j.autrev.2023.103375","article-title":"Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature","volume":"22","author":"Guerra","year":"2023","journal-title":"Autoimmun Rev"},{"key":"2026100106251933000_19.10.e275507.15","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/mrcr\/rxad007","article-title":"Anti-TIF1\u03b3 antibody-positive dermatomyositis associated with nivolumab administration in a patient with advanced oesophageal squamous cell carcinoma: A case report and literature review","volume":"7","author":"Sakurai","year":"2023","journal-title":"Mod Rheumatol Case Rep"},{"key":"2026100106251933000_19.10.e275507.16","doi-asserted-by":"publisher","DOI":"10.1002\/art.38093"},{"key":"2026100106251933000_19.10.e275507.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1402225"},{"key":"2026100106251933000_19.10.e275507.18","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJMra2415426","article-title":"Inflammatory Myopathies","volume":"394","author":"Allenbach","year":"2026","journal-title":"N Engl J Med"},{"key":"2026100106251933000_19.10.e275507.19","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jamaoncol.2018.5441","article-title":"Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus: The Phase 2 KEYNOTE-180 Study","volume":"5","author":"Shah","year":"2019","journal-title":"JAMA Oncol"},{"key":"2026100106251933000_19.10.e275507.20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01888"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2026-275507","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:43:44Z","timestamp":1790862224000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2026-275507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":20,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,1]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1136\/bcr-2026-275507"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2026-275507","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}